Theophylline



Compound IDCDAMM02079
Common nameTheophylline
IUPAC name1,3-dimethyl-7H-purine-2,6-dione
Molecular formulaC7H8N4O2

Experimental data

Retention time0.44
Adduct[M+H]+
Actual mz181.072
Theoretical mz181.072
Error0.13
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.9407

Identifiers and class information

Inchi keyZFXYFBGIUFBOJW-UHFFFAOYSA-N
SmilesO=C1C=2NC=NC2N(C(=O)N1C)C
SuperclassOrganoheterocyclic compounds
ClassImidazopyrimidines

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)0
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)180.166
Computed dipole moment(dipole)4.984
Total solvent accessible surface area (SASA)369.372
Hydrophobic component of SASA (FOSA)157.526
Hydrophilic component of SASA (FISA)142.839
Pie component of the SASA (PISA)69.007
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)585.071
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)5
Free energy of solvation of dipole (dip^2/V)0.042457
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0135365
Globularity descriptor (glob)0.915882
Predicted polarizability in cubic angstroms (QPpolrz)17.92
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.477
Predicted octanol/gas partition coefficient (QPlogPoct)10.247
Predicted water/gas partition coefficient (QPlogPw)8.439
Predicted octanol/water partition coefficient (QPlogPo/w)-0.02
Predicted aqueous solubility (QPlogS)-1.394
Conformation-independent predicted aqueous solubility (CIQPlogS)-1.594
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.222
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)437.887
Predicted brain/blood partition coefficient (QPlogBB)-0.572
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)202.631
Predicted skin permeability, log Kp (QPlogKp)-3.909
PM3 calculated ionization potential (IP(ev))9.087
PM3 calculated electron affinity (EA(eV))0.535
Number of likely metabolic reactions (#metab)0
Prediction of binding to human serum albumin (QPlogKhsa)-0.619
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)74.105
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)87.411
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P22303ACHEAcetylcholinesteraseT30082SwissTargetPrediction
Q12809KCNH2HERGT20251SwissTargetPrediction
P29274ADORA2AAdenosine A2a receptorT77365SwissTargetPrediction and SEA
P30542ADORA1Adenosine A1 receptorT92072SwissTargetPrediction and SEA
P0DMS8ADORA3Adenosine A3 receptorT36059SwissTargetPrediction
P21397MAOAMonoamine oxidase AT83875SEA
P27338MAOBMonoamine oxidase BT83011SEA
P29275ADORA2BAdenosine A2b receptorT86679SwissTargetPrediction and SEA
Q9Y2T3GDAGuanine deaminaseT92460SEA
P54750PDE1APhosphodiesterase 1AT81637SEA
Q9Y6Q9NCOA3Nuclear receptor coactivator 3T26774SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T30082DI0025Alzheimer disease[ICD-11: 8A20]P22303ACHE
T30082DI0166Glaucoma[ICD-11: 9C61]P22303ACHE
T30082DI0282Myasthenia gravis[ICD-11: 8C6Y]P22303ACHE
T30082DI0313Oesophageal/gastroduodenal disorder[ICD-11: DD90]P22303ACHE
T30082DI0332Pediculosis[ICD-11: 1G00]P22303ACHE
T30082DI0421Unspecific substance harmful effect[ICD-11: NE6Z]P22303ACHE
T20251DI0175Heart failure[ICD-11: BD10-BD1Z]Q12809KCNH2
T77365DI0319Orthostatic hypotension[ICD-11: BA21]P29274ADORA2A
T77365DI0331Parkinsonism[ICD-11: 8A00]P29274ADORA2A
T77365DI0359Radionuclide imaging[ICD-11: N.A.]P29274ADORA2A
T92072DI0319Orthostatic hypotension[ICD-11: BA21]P30542ADORA1
T36059DI0351Psoriasis[ICD-11: EA90]P0DMS8ADORA3
T36059DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P0DMS8ADORA3
T83875DI0117Depression[ICD-11: 6A70-6A7Z]P21397MAOA
T83875DI0331Parkinsonism[ICD-11: 8A00]P21397MAOA
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T86679DI0180Herpes simplex infection[ICD-11: 1F00]P29275ADORA2B
T86679DI0397Supraventricular tachyarrhythmia[ICD-11: BC81]P29275ADORA2B

Copyright © 2025